Profile
| Metric | Value |
|---|---|
| Full Name | LivaNova PLC |
| Ticker | NASDAQ: LIVN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United Kingdom |
| IPO | |
| Indexes | Not included |
| Website | livanova.com |
| Employees | 2,900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $63.16 | |
| Price, 1D Change | -1.13% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.93 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +8.66% | |
| EPS | $1.16 | |
| EPS, 1Y Change | +257.95% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $1.16 | |
| EPS Estimate | $3.86 | |
| EPS Est. Change | +233.49% | |
| Revenue | $1.25B | |
| Revenue Estimate | $1.38B | |
| Revenue Est. Change | +9.98% | |
| Current Price | $63.16 | |
| Price Target | - | $70.00 |
| Price Tgt. Change | - | +10.83% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.70 | $0.32 | -88.01% | |
| $3.33 | $1.16 | -65.25% | |
| $3.86 | N/A | +233.49% | |
| $4.13 | N/A | +256.62% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.13B | $1.15B | +2.00% | |
| $1.25B | $1.25B | +0.65% | |
| $1.38B | N/A | +9.98% | |
| $1.47B | N/A | +17.17% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +29.37% | |
| Price, 3Y | +10.55% | |
| Market Cap, 1Y | +29.98% | |
| Market Cap, 3Y | +12.70% | |
| Revenue, 1Y | +8.66% | |
| Revenue, 3Y | +21.06% | |
| EPS, 1Y | +257.95% | |
| EPS, 3Y | +143.20% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $63.16 | |
| SMA 200 | $50.97 | |
| SMA 200 vs Price | -19.30% | |
| SMA 50 | $61.44 | |
| SMA 50 vs Price | -2.73% | |
| Beta | 0.93 | |
| ATR | $1.60 | |
| 14-Day RSI | 53.01 | |
| 10-Day Volatility | 31.37% | |
| 1-Year Volatility | 45.89% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.25B | |
| EPS | $1.16 | |
| Gross Profit | $872.17M | |
| Gross Margin | 69.58% | |
| Operating Profit | $165.44M | |
| Operating Margin | 13.20% | |
| Net Income | $63.23M | |
| Net Margin | 5.04% | |
| EBITDA | $216.58M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.51 | |
| Current Ratio | 2.87 | |
| Quick Ratio | 2.50 | |
| - | ||
| F-Score | 4 | |
| Altman Z-Score | 2.31 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 2.56 | |
| PB Ratio | 2.98 | |
| EV/EBITDA | -30.68 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.32B | |
| Cash & Equivalents | $428.86M | |
| Total Assets | $2.51B | |
| Current Assets | $1.13B | |
| Total Liabilities | $1.19B | |
| Current Liabilities | $392.13M | |
| Total Debt | $676.77M | |
| Short Term Debt | $87.04M | |
| Accounts Payable | $69.73M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.19B | |
| Operating Expenses | $706.74M | |
| Cost Of Goods Sold | $381.26M | |
| SG&A | $0.00 | |
| D&A | $51.14M | |
| Interest Expense | $0.00 | |
| Income Tax | $25.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $183.04M | |
| CFI | -$48.16M | |
| CFF | $18.55M | |
| Capex | $47.11M | |
| Free Cash Flow | $135.93M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | → | |
| Stifel | → | |
| Keybanc | ||
| Mizuho | → | |
| Mizuho | → | |
| Baird | → | |
| Baird | → | |
| Needham | → | |
| Barclays | → | |
| Wolfe Research | → |
Analyst sentiment
Institutional ownership
Screeners with LIVN
FAQ
What is the ticker symbol for LivaNova PLC?
The ticker symbol for LivaNova PLC is NASDAQ:LIVN
Does LivaNova PLC pay dividends?
No, LivaNova PLC does not pay dividends
What sector is LivaNova PLC in?
LivaNova PLC is in the Healthcare sector
What industry is LivaNova PLC in?
LivaNova PLC is in the Medical Devices industry
What country is LivaNova PLC based in?
LivaNova PLC is headquartered in United Kingdom
When did LivaNova PLC go public?
LivaNova PLC initial public offering (IPO) was on October 19, 2015
Is LivaNova PLC in the S&P 500?
No, LivaNova PLC is not included in the S&P 500 index
Is LivaNova PLC in the NASDAQ 100?
No, LivaNova PLC is not included in the NASDAQ 100 index
Is LivaNova PLC in the Dow Jones?
No, LivaNova PLC is not included in the Dow Jones index
When was LivaNova PLC last earnings report?
LivaNova PLC's most recent earnings report was on November 5, 2025
When does LivaNova PLC report earnings?
The next expected earnings date for LivaNova PLC is February 25, 2026
Data Sources & References
- LIVN Official Website www.livanova.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1639691/000163969125000150/0001639691-25-000150-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1639691/000163969125000010/0001639691-25-000010-index.htm
- LIVN Profile on Yahoo Finance finance.yahoo.com/quote/LIVN
- LIVN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/livn